CCAAT/Enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Van Der Krieken, Sophie E ^a   Popeijus, Herman E ^a   Mensink, Ronald P ^a   Plat, Jogchum ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; TRIACYLGLYCEROL;

ADIPOCYTE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL MATURATION; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; GENE DELETION; GENE TARGETING; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN METABOLISM; METABOLIC DISORDER; METABOLIC REGULATION; MOLECULAR MECHANICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; REVIEW; ANIMAL; ENDOPLASMIC RETICULUM; GENETICS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALIA; MUS;

ADIPOCYTES; ADIPOSE TISSUE, BROWN; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMANS; INFLAMMATION; MICE;

EID: 84933059655     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/324815     Document Type: Review

References (122)

1. U. Salmenniemi, E. Ruotsalainen, J. Pihlajamäki et al., "Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome, " Circulation, vol. 110, no. 25, pp. 3842-3848, 2004.
2. P. T. James, N. Rigby, and R. Leach, "The obesity epidemic, metabolic syndrome and future prevention strategies, " The European Journal of Cardiovascular Prevention and Rehabilitation, vol. 11, no. 1, pp. 3-8, 2004.
3. R. S. Ahima, "Adipose tissue as an endocrine organ, " Obesity, vol. 14, no. S8, pp. 242S-249S, 2006.
4. M. Visser, L.M. Bouter, G. M. McQuillan, M. H. Wener, and T. B. Harris, "Elevated C-reactive protein levels in overweight and obese adults, " The Journal of the American Medical Association, vol. 282, no. 22, pp. 2131-2135, 1999.
5. I. Juhan-Vague, M.-C.Alessi, A.Mavri, and P.E.Morange, "Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk, " Journal of Thrombosis and Haemostasis, vol. 1, no. 7, pp. 1575-1579, 2003.
6. J. S. Yudkin, "Adipose tissue, insulin action and vascular disease: inflammatory signals, " International Journal of Obesity, vol. 27, supplement 3, pp. S25-S28, 2003.
7. R. Ross and B. Dodet, "Atherosclerosis is an inflammatory disease, "American Heart Journal, vol. 138, no. 5, part2, pp. S419-S420, 1999.
8. S. M. Haffner, "Insulin resistance, inflammation, and the prediabetic state, "The American Journal of Cardiology, vol. 92, no. 4A, pp. 18J-26J, 2003.
9. D. P. Ramji and P. Foka, "CCAAT/enhancer-binding proteins: structure, function and regulation, " Biochemical Journal, vol. 365, part 3, pp. 561-575, 2002.
10. M. C. E. Bragt and H. E. Popeijus, "Peroxisome proliferatoractivated receptors and the metabolic syndrome, " Physiology and Behavior, vol. 94, no. 2, pp. 187-197, 2008.
11. R. G. Baker, M. S. Hayden, and S. Ghosh, "NF-κB, inflammation, and metabolic disease, " Cell Metabolism, vol. 13, no. 1, pp. 11-22, 2011.
12. K. Iizuka and Y. Horikawa, "ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome, " Endocrine Journal, vol. 55, no. 4, pp. 617-624, 2008.
13. C. A. Millward, J. D. Heaney, D. S. Sinasac et al., "Mice with a deletion in the gene for CCAAT/enhancer-binding protein β are protected against diet-induced obesity, " Diabetes, vol. 56, no. 1, pp. 161-167, 2007.
14. Y. Sato, Y. Nishio, O. Sekine et al., "Increased expression of CCAAT/enhancer binding protein-beta and-delta and monocyte chemoattractant protein-1 genes in aortas from hyperinsulinaemic rats, " Diabetologia, vol. 50, no. 2, pp. 481-489, 2007.
15. J. Tsukada, Y. Yoshida, Y. Kominato, and P. E. Auron, "The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation, " Cytokine, vol. 54, no. 1, pp. 6-19, 2011.
16. Z. Cao, R. M. Umek, and S. L.Mc Knight, "Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells, " Genes & Development, vol. 5, no. 9, pp. 1538-1552, 1991.
17. S. C. Williams, C. A. Cantwell, and P. F. Johnson, "A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro, " Genes and Development, vol. 5, no. 9, pp. 1553-1567, 1991.
18. P. Antonson and K. G. Xanthopoulos, "Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein α (C/EBPα), " Biochemical and Biophysical Research Communications, vol. 215, no. 1, pp. 106-113, 1995.
19. J. Lekstrom-Himes and K. G. Xanthopoulos, "Biological role of the CCAAT/enhancer-binding protein family of transcription factors, " The Journal of Biological Chemistry, vol. 273, no. 44, pp. 28545-28548, 1998.
20. M. Lut, J. Seufert, and J. F. Habener, "Pancreatic β-cell-specific repression of insulin gene transcription by CCAAT/enhancerbinding protein β: inhibitory interactions with basic helix loop-helix transcription factor E47, " Journal of Biological Chemistry, vol. 272, no. 45, pp. 28349-28359, 1997.
21. S. Akira, H. Isshiki, T. Sugita et al., "A nuclear factor for IL-6 expression (NF-IL6) is amember of a C/EBP family, "TheEMBO Journal, vol. 9, no. 6, pp. 1897-1906, 1990.
22. V. Poli, F. P. Mancini, and R. Cortese, "IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a newfamily of leucine zipper proteins related toC/EBP, " Cell, vol. 63, no. 3, pp. 643-653, 1990.
23. P. Descombes, M. Chojkier, S. Lichtsteiner, E. Falvey, and U. Schibler, "LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein, " Genes & Development, vol. 4, no. 9, pp. 1541-1551, 1990.
24. C.-J. Chang, T.-T. I. Chen, H.-Y. Lei, D.-S. Chen, and S.-C. Lee, "Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family, " Molecular and Cellular Biology, vol. 10, no. 12, pp. 6642-6653, 1990.
25. S. Katz, E. Kowenz-Leutz, C. Muller, K. Meese, S. A. Ness, and A. Leutz, "The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avianmyelomonocytic cells, "TheEMBO Journal, vol. 12, no. 4, pp. 1321-1332, 1993.
26. S. Kinoshita, S. Akira, and T. Kishimoto, "A member of the C/EBP family, NF-IL6β, forms a heterodimer and transcriptionally synergizes with NF-IL6, " Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 4, pp. 1473-1476, 1992.
27. A. M. Chumakov, I. Grillier, E. Chumakova, D. Chih, J. Slater, and H. P. Koeffler, "Cloning of the novel human myeloid-cellspecific C/EBP-ε transcription factor, " Molecular and Cellular Biology, vol. 17, no. 3, pp. 1375-1386, 1997.
28. R. Yamanaka, G.-D. Kim, H. S. Radomska et al., "CCAAT/enhancer binding protein ε is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing, " Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6462-6467, 1997.
29. C. Roman, J. S. Platero, J. Shuman, and K. Calame, "Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP, " Genes & Development, vol. 4, no. 8, pp. 1404-1415, 1990.
30. D. Ron and J. F. Habener, "CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription, " Genes and Development, vol. 6, no. 3, pp. 439-453, 1992.
31. I. Screpanti, L. Romani, P. Musiani et al., "Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ-deficient mice, " The EMBO Journal, vol. 14, no. 9, pp. 1932-1941, 1995.
32. T. Tanaka, S. Akira, K. Yoshida et al., "Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages, " Cell, vol. 80, no. 2, pp. 353-361, 1995.
33. L. E. Greenbaum, W. Li, D. E. Cressman et al., "CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy, " The Journal of Clinical Investigation, vol. 102, no. 5, pp. 996-1007, 1998.
34. A. L.Welm, S. L.Mackey, L. T. Timchenko, G. J.Darlington, and N. A. Timchenko, "Translational induction of liver-enriched transcriptional inhibitory protein during acute phase response leads to repression of CCAAT/Enhancer protein α mRNA, " The Journal of Biological Chemistry, vol. 275, no. 35, pp. 27406-27413, 2000.
35. P. Descombes and U. Schibler, "A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated fromthe same mRNA, " Cell, vol. 67, no. 3, pp. 569-579, 1991.
36. V. Ossipow, P. Descombes, and U. Schibler, "CCAAT/enhancerbinding protein mRNA is translated intomultiple proteins with different transcription activation potentials, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 8219-8223, 1993.
37. F.-T. Lin, O. A.MacDougald, A. M. Diehl, and M. D. Lane, "A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking antimitotic activity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 20, pp. 9606-9610, 1993.
38. T. Tatusova, S. Ciufo, B. Fedorov, K. O'Neill, and I. Tolstoy, "RefSeq microbial genomes database: new representation and annotation strategy, " Nucleic Acids Research, vol. 42, no. 1, pp. D553-D559, 2014.
39. S. C.Williams, M. Baer, A. J. Dillner, and P. F. Johnson, "CRP2 (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity, " The EMBO Journal, vol. 14, no. 13, pp. 3170-3183, 1995.
40. M. Niehof, S. Kubicka, L. Zender, M. P. Manns, and C. Trautwein, "Autoregulation enables different pathways to control CCAAT/enhancer binding protein β (C/EBPβ) transcription, " Journal of Molecular Biology, vol. 309, no. 4, pp. 855-868, 2001.
41. M. Rebhan, V. Chalifa-Caspi, J. Prilusky, and D. Lancet, "Gene-Cards: integrating information about genes, proteins and diseases, " Trends in Genetics, vol. 13, no. 4, p. 163, 1997.
42. A. Berrier, G. Siu, and K. Calame, "Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells, " Journal of Immunology, vol. 161, no. 5, pp. 2267-2275, 1998.
43. M. Matsumoto, Y. Sakao, and S. Akira, "Inducible expression of nuclear factor IL-6 increases endogenous gene expression of macrophage inflammatory protein-1α, osteopontin and CD14 in a monocytic leukemia cell line, " International Immunology, vol. 10, no. 12, pp. 1825-1835, 1998.
44. Y. Chen, S. Zhuang, S. Cassenaer et al., "Synergism between calcium and cyclic GMP in cyclic AMP response elementdependent transcriptional regulation requires cooperation between CREB and C/EBP-β, " Molecular and Cellular Biology, vol. 23, no. 12, pp. 4066-4082, 2003.
45. X. Mo, E. Kowenz-Leutz, H. Xu, and A. Leutz, "Ras induces mediator complex exchange onC/EBP beta, "MolecularCell, vol. 13, no. 2, pp. 241-250, 2004.
46. S. L. Lay, I. Lefrère, C. Trautwein, I. Dugail, and S.Krief, "Insulin and sterol-regulatory element-binding protein-1c (SREBP-1c) regulation of gene expression in 3T3-L1 adipocytes: identification of CCAAT/enhancer-binding protein β as an SREBP-1c target, "The Journal of Biological Chemistry, vol. 277, no. 38, pp. 35625-35634, 2002.
47. T. Hattori, N. Ohoka, H. Hayashi, and K. Onozaki, "C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoform, " FEBS Letters, vol. 541, no. 1-3, pp. 33-39, 2003.
48. E. Duprez, K. Wagner, H. Koch, and D. G. Tenen, "C/EBPβ: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells, " The EMBO Journal, vol. 22, no. 21, pp. 5806-5816, 2003.
49. T. Kuilman, C. Michaloglou, L. C. W. Vredeveld et al., "Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network, " Cell, vol. 133, no. 6, pp. 1019-1031, 2008.
50. S. Mink, B. Haenig, and K.-H. Klempnauer, "Interaction and functional collaboration of p300 and C/EBPβ, " Molecular and Cellular Biology, vol. 17, no. 11, pp. 6609-6617, 1997.
51. S. Mink, S. Jaswal, O. Burk, and K.-H. Klempnauer, "The v-Myb oncoprotein activates C/EBPβ expression by stimulating an autoregulatory loop at the C/EBPβ promoter, " Biochimica et Biophysica Acta-Gene Structure and Expression, vol. 1447, no. 2-3, pp. 175-184, 1999.
52. D. Foti, R. Iuliano, E. Chiefari, and A. Brunetti, "A nucleoprotein complex containing Sp1, C/EBPβ, and HMGI-Y controls human insulin receptor gene transcription, " Molecular and Cellular Biology, vol. 23, no. 8, pp. 2720-2732, 2003.
53. W. Chang, A. Rewari, M. Centrella, and T. L. McCarthy, "Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-binding protein β expression in osteoblasts, " The Journal of Biological Chemistry, vol. 279, no. 41, pp. 42438-42444, 2004.
54. Y. Xie, C. Chen, M. A. Stevenson, P. E. Auron, and S. K. Calderwood, "Heat shock factor 1 represses transcription of the IL-1β gene through physical interaction with the nuclear factor of interleukin 6, "The Journal of Biological Chemistry, vol. 277, no. 14, pp. 11802-11810, 2002.
55. Z. Chen, J. I. Torrens, A. Anand, B. M. Spiegelman, and J. M. Friedman, "Krox20 stimulates adipogenesis via C/EBPβ-dependent and-independent mechanisms, " Cell Metabolism, vol. 1, no. 2, pp. 93-106, 2005.
56. E. Kowenz-Leutz and A. Leutz, "A C/EBPβ isoform recruits the SWI/SNF complex to activate myeloid genes, " Molecular Cell, vol. 4, no. 5, pp. 735-743, 1999.
57. M. Niehof, K. Streetz, T. Rakemann et al., "Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPβ promoter suggests a new mechanism of transcriptional regulation by STAT3, "The Journal of Biological Chemistry, vol. 276, no. 12, pp. 9016-9027, 2001.
58. K. P. LeClair, M. A. Blanar, and P. A. Sharp, "The p50 subunit of NF-κB associates with the NF-IL6 transcription factor, " Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 8145-8149, 1992.
59. C. J. Chang, Y. L. Chen, and S. C. Lee, "Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression, " Molecular and Cellular Biology, vol. 18, no. 10, pp. 5880-5887, 1998.
60. F. Zhang, M. Lin, P. Abidi, G. Thiel, and J. Liu, "Specific interaction of Egr1 and c/EBPβ leads to the transcriptional activation of the human low density lipoprotein receptor gene, " Journal of Biological Chemistry, vol. 278, no. 45, pp. 44246-44254, 2003.
61. J. Coyle-Rink, T. M. Sweet, S. Abraham et al., "Interaction between TGFβ signaling proteins and C/EBP controls basal and tat-mediated transcription of HIV-1 LTR in astrocytes, " Virology, vol. 299, no. 2, pp. 240-247, 2002.
62. J.D. Shuman, J. Cheong, and J. E. Coligan, "ATF-2 and C/EBPα can form a heterodimeric DNA binding complex in vitro: functional implications for transcriptional regulation, " Journal of Biological Chemistry, vol. 272, no. 19, pp. 12793-12800, 1997.
63. L. M. Podust, A. M. Krezel, and Y. Kim, "Crystal structure of the CCAAT box/enhancer-binding protein β activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA, " The Journal of Biological Chemistry, vol. 276, no. 1, pp. 505-513, 2001.
64. M.Christian, X. Zhang, T. Schneider-Merck et al., "Cyclic AMPinduced forkhead transcription factor, FKHR, cooperates with CCAAT/enhancer-binding protein β in differentiating human endometrial stromal cells, "The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20825-20832, 2002.
65. M. Boruk, J. G. A. Savory, and R. J. G. Haché, "AF-2-dependent potentiation of CCAAT enhancer binding protein β-mediated transcriptional activation by glucocorticoid receptor, " Molecular Endocrinology, vol. 12, no. 11, pp. 1749-1763, 1998.
66. R. Metz and E. Ziff, "cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription, " Genes and Development, vol. 5, no. 10, pp. 1754-1766, 1991.
67. Y. Zuo, L. Qiang, and S. R. Farmer, "Activation of CCAAT/enhancer-binding protein (C/EBP) α expression by C/EBPβ during adipogenesis requires a peroxisome proliferator-activated receptor-γ-associated repression of HDAC1 at the C/ebpα gene promoter, " Journal of Biological Chemistry, vol. 281, no. 12, pp. 7960-7967, 2006.
68. Z.Wu, Y. Xie, N. L. R. Bucher, and S. R. Farmer, "Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis, " Genes & Development, vol. 9, no. 19, pp. 2350-2363, 1995.
69. E. A. Park, A. L. Gurney, S. E. Nizielski et al., "Relative roles of CCAAT/enhancer-binding protein β and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP), " The Journal of Biological Chemistry, vol. 268, no. 1, pp. 613-619, 1993.
70. C. Trautwein, T. Rakemann, A. Pietrangelo, J. Plümpe, G. Montosi, and M. P. Manns, "C/EBP-β/LAP controls downregulation of albumin gene transcription during liver regeneration, " The Journal of Biological Chemistry, vol. 271, no. 36, pp. 22262-22270, 1996.
71. G. K. Chen, S. Sale, T. Tan, R. P. Ermoian, and B. I. Sikic, "CCAAT/enhancer-binding protein β (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells, "Molecular Pharmacology, vol. 65, no. 4, pp. 906-916, 2004.
72. M. Kozak, "The scanningmodel for translation: an update, " The Journal of Cell Biology, vol. 108, no. 2, pp. 229-241, 1989.
73. N. A. Timchenko, A. L. Welm, X. Lu, and L. T. Timchenko, "CUG repeat binding protein (CUGBP1) interacts with the 5′ region of C/EBPβ mRNA and regulates translation of C/EBPβ isoforms, " Nucleic Acids Research, vol. 27, no. 22, pp. 4517-4525, 1999.
74. A. L.Welm, N. A. Timchenko, and G. J. Darlington, "C/EBPα regulates generation of C/EBPβ isoforms through activation of specific proteolytic cleavage, " Molecular and Cellular Biology, vol. 19, no. 3, pp. 1695-1704, 1999.
75. O. Meir, E. Dvash, A. Werman, and M. Rubinstein, "C/EBP-β regulates endoplasmic reticulum stress-triggered cell death in mouse and human models, " PLoS ONE, vol. 5, no. 3, Article ID e9516, 2010.
76. L. Busetto, "Visceral obesity and the metabolic syndrome: effects of weight loss, "Nutrition, Metabolismand Cardiovascular Diseases, vol. 11, no. 3, pp. 195-204, 2001.
77. P.M.Clifton, J. B. Keogh, P. R. Foster, and M. Noakes, "Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets, " International Journal of Obesity, vol. 29, no. 12, pp. 1445-1451, 2005.
78. J. Staiger, M. J. Lueben, D. Berrigan et al., "C/EBPβ regulates body composition, energy balance-related hormones and tumor growth, " Carcinogenesis, vol. 30, no. 5, pp. 832-840, 2009.
79. P. Yubero, C. Manchado, A.-M. Cassard-Doulcier et al., "CCAAT/enhancer binding proteins α and β are transcriptional activators of the brown fat uncoupling protein gene promoter, " Biochemical and Biophysical Research Communications, vol. 198, no. 2, pp. 653-659, 1994.
80. C. Manchado, P. Yubero, O. Vinas et al., "CCAAT/enhancerbinding proteins α and β in brown adipose tissue: evidence for a tissue-specific pattern of expression during development, " Biochemical Journal, vol. 302, no. 3, pp. 695-700, 1994.
81. T. Tanaka, N. Yoshida, T. Kishimoto, and S. Akira, "Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPρ gene, "TheEMBOJournal, vol. 16, no. 24, pp. 7432-7443, 1997.
82. S. S. Chung, J. S. Lee, M. Kim et al., "Regulation of Wnt/β-catenin signaling by CCAAT/enhancer binding protein β during adipogenesis, " Obesity, vol. 20, no. 3, pp. 482-487, 2012.
83. J. K. Hamm, B. H. Park, and S. R. Farmer, "A role for C/EBPβ in regulating peroxisome proliferator-activated receptor γ activity during adipogenesis in 3T3-L1 preadipocytes, " The Journal of Biological Chemistry, vol. 276, no. 21, pp. 18464-18471, 2001.
84. W. C. Yeh, Z. Cao, M. Classon, and S. L. McKnight, "Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins, " Genes and Development, vol. 9, no. 2, pp. 168-181, 1995.
85. Z.Wu, Y. Xie, R. F. Morrison, N. L.R. Bucher, and S. R. Farmer, "PPARγ induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPα during the conversion of 3T3 fibroblasts into adipocytes, " Journal of Clinical Investigation, vol. 101, no. 1, pp. 22-32, 1998.
86. H.-Y. Shao, H.-Y. Hsu, K.-S.Wu, S.-W. Hee, L.-M. Chuang, and J.-I. Yeh, "Prolonged Induction Activates Cebpα Independent Adipogenesis in NIH/3T3 Cells, " PLoS ONE, vol. 8, no. 1, Article ID e51459, 2013.
87. M.D.Klok, S. Jakobsdottir, and M. L. Drent, "The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review, " Obesity Reviews, vol. 8, no. 1, pp. 21-34, 2007.
88. P.Chedraui, F. R. Pérez-López, G. S. Escobar et al., "Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome, " Maturitas, vol. 79, no. 1, pp. 86-90, 2014.
89. M. M. Mason, Y. He, H. Chen, M. J. Quon, and M. Reitman, "Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor, " Endocrinology, vol. 139, no. 3, pp. 1013-1022, 1998.
90. F. Bosch, J. Sabater, and A. Valera, "Insulin inhibits liver expression of the CCAAT/enhancer-binding protein β, " Diabetes, vol. 44, no. 3, pp. 267-271, 1995.
91. J. Seufert, G. C. Weir, and J. F. Habener, "Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein β and transactivator islet duodenum homeobox-1 in rat pancreatic β cells during the development of diabetes mellitus, " Journal of Clinical Investigation, vol. 101, no. 11, pp. 2528-2539, 1998.
92. T. Matsuda, Y. Kido, S.-I. Asahara et al., "Ablation of C/EBPβ alleviates ER stress and pancreatic β cell failure through the GRP78 chaperone in mice, "The Journal of Clinical Investigation, vol. 120, no. 1, pp. 115-126, 2010.
93. S. Liu, C. Croniger, C. Arizmendi et al., "Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene, " The Journal of Clinical Investigation, vol. 103, no. 2, pp. 207-213, 1999.
94. C. M. Croniger, C.Millward, J. Yang et al., "Mice with a deletion in the gene for CCAAT/enhancer-binding protein β have an attenuated response to cAMP and impaired carbohydrate metabolism, " The Journal of Biological Chemistry, vol. 276, no. 1, pp. 629-638, 2001.
95. L. Madsen and K. Kristiansen, "The importance of dietary modulation of cAMP and insulin signaling in adipose tissue and the development of obesity, " Annals of the New York Academy of Sciences, vol. 1190, pp. 1-14, 2010.
96. K. H. Kaestner, R. J. Christy, and M. D. Lane, "Mouse insulinresponsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein, " Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 1, pp. 251-255, 1990.
97. H. Yamamoto, S. Kurebayashi, T. Hirose, H. Kouhara, and S. Kasayama, "Reduced IRS-2 and GLUT4 expression in PPARγ2-induced adipocytes derived from C/ECPβ and C/EBPρ-deficient mouse embroyonic fibroblasts, " Journal of Cell Science, vol. 115, no. 18, pp. 3601-3607, 2002.
98. L.Wang, J. Shao, P.Muhlenkamp et al., "Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein β, " Journal of Biological Chemistry, vol. 275, no. 19, pp. 14173-14181, 2000.
99. S. M. Rahman, R. C. Janssen, M. Choudhury et al., "CCAAT/enhancer-binding protein β (C/EBPβ) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice, " The Journal of Biological Chemistry, vol. 287, no. 41, pp. 34349-34360, 2012.
100. J. M. Schroeder-Gloeckler, S. M. Rahman, R. C. Janssen et al., "CCAAT/enhancer-binding protein β deletion reduces adiposity, hepatic steatosis, and diabetes in Leprdb/db mice, " The Journal of Biological Chemistry, vol. 282, no. 21, pp. 15717-15729, 2007.
101. P. Angulo, "Nonalcoholic fatty liver disease, " The New England Journal of Medicine, vol. 346, no. 16, pp. 1221-1231, 2002.
102. S. M. Rahman, J. M. Schroeder-Gloeckler, R. C. Janssen et al., "CCAAT/enhancing binding protein β deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis, " Hepatology, vol. 45, no. 5, pp. 1108-1117, 2007.
103. A. Vitale and J. Denecke, "The endoplasmic reticulum-gateway of the secretory pathway, " Plant Cell, vol. 11, no. 4, pp. 615-628, 1999.
104. S. Banerjee, Y. Zhao, P. S. Sarkar, K. P. Rosenblatt, R. G. Tilton, and S. Choudhary, "Klotho ameliorates chemically induced endoplasmic reticulum (ER) stress signaling, " Cellular Physiology and Biochemistry, vol. 31, no. 4-5, pp. 659-672, 2013.
105. I. Kim, W. Xu, and J. C. Reed, "Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities, " Nature Reviews Drug Discovery, vol. 7, no. 12, pp. 1013-1030, 2008.
106. Y. Li, Y. Guo, J. Tang, J. Jiang, and Z. Chen, "New insights into the roles of CHOP-induced apoptosis in ER stress, " Acta Biochimica et Biophysica Sinica, vol. 46, no. 8, pp. 629-640, 2014.
107. Y. Li, E. Bevilacqua, C.-B. Chiribau et al., "Differential control of the CCAAT/enhancer-binding protein β (C/EBPβ) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress, " The Journal of Biological Chemistry, vol. 283, no. 33, pp. 22443-22456, 2008.
108. A. Cloutier, C.Guindi, P. Larivée, C.M. Dubois, A.Amrani, and P. P.McDonald, "Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors, " Journal of Immunology, vol. 182, no. 1, pp. 563-571, 2009.
109. C. Trautwein, C. Caelles, P. Van der Geer, T. Hunter, M. Karin, and M. Chojkier, "Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain, " Nature, vol. 364, no. 6437, pp. 544-547, 1993.
110. E.S.Hungness, G. J. Luo, T. A. Pritts et al., "Transcription factors C/EBP-β and-ρ regulate IL-6 production in IL-1β-stimulated human enterocytes, " Journal of Cellular Physiology, vol. 192, no. 1, pp. 64-70, 2002.
111. G. G. Wannamethee, P. H. Whincup, A. Rumley, and G. D. O. Lowe, "Inter-relationships of interleukin-6, cardiovascular risk factors and themetabolic syndrome among older men, " Journal of Thrombosis and Haemostasis, vol. 5, no. 8, pp. 1637-1643, 2007.
112. N. M. Harder-Lauridsen, R. Krogh-Madsen, J. J. Holst et al., "Effect of IL-6 on the insulin sensitivity in patients with type 2 diabetes, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 306, no. 7, pp. E769-E778, 2014.
113. M. R. An, C. C. Hsieh, P. D. Reisner et al., "Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response, " Molecular and Cellular Biology, vol. 16, no. 5, pp. 2295-2306, 1996.
114. V. Poli, "Therole of C/EBP isoforms in the control of inflammatory and native immunity functions, " The Journal of Biological Chemistry, vol. 273, no. 45, pp. 29279-29282, 1998.
115. C. Yan, M. Zhu, J. Staiger, P. F. Johnson, and H. Gao, "C5aregulated CCAAT/enhancer-binding proteins β and ρ are essential in Fcγ receptor-mediated inflammatory cytokine and chemokine production in macrophages, " The Journal of Biological Chemistry, vol. 287, no. 5, pp. 3217-3230, 2012.
116. G. Luc, J. M. Bard, J. Ferrières et al., "Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1155-1161, 2002.
117. P. J. Barter and K.-A. Rye, "Relationship between the concentration and antiatherogenic activity of high-density lipoproteins, " Current Opinion in Lipidology, vol. 17, no. 4, pp. 399-403, 2006.
118. D. J. Rader and A. R. Tall, "The not-so-simple HDL story: is it time to revise the HDL cholesterol hypothesis?" Nature Medicine, vol. 18, no. 9, pp. 1344-1346, 2012.
119. S. M. Boekholdt, B. J. Arsenault, G. K. Hovingh et al., "Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis, " Circulation, vol. 128, no. 14, pp. 1504-1512, 2013.
120. S. E. Nissen, T. Tsunoda, E. M. Tuzcu et al., "Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, " Journal of the AmericanMedical Association, vol. 290, no. 17, pp. 2292-2300, 2003.
121. L. J. Leman, B. E. Maryanoff, and M. R. Ghadiri, "Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis, " Journal of Medicinal Chemistry, vol. 57, no. 6, pp. 2169-2196, 2014.
122. H.-Y. Kan, S. Georgopoulos, M. Zanni et al., "Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice, " Biochemistry, vol. 43, no. 17, pp. 5084-5093, 2004.